Erratum: MicroRNA-130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin β1 (PLoS ONE 9:2 (2014) e87938 DOI:10.1371/journal.pone.0087938);Microrna 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Zhao, Yanyang ^a   Miao, Gang ^a   Li, Yao ^a   Isaji, Tomoya ^b   Gu, Jianguo ^b   Li, Jian ^a   Qi, Ruomei ^a  

^a BEIJING HOSPITAL   (China)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; LUCIFERASE; MICRORNA; MICRORNA 130; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MICROARRAY ANALYSIS; MIGRATION INHIBITION; NUCLEOTIDE SEQUENCE; TUMOR INVASION; UPREGULATION;

ANTIGENS, CD29; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84896899488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091498     Document Type: Erratum

References (48)

1. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
2. Kato M, Slack FJ (2008) microRNAs: small molecules with big roles - C. elegans to human cancer. Biol Cell 100: 71-81. (Pubitemid 351266765)
3. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6: 590-610.
4. Wang W, Peng B, Wang D, Ma X, Jiang D, et al. (2010) Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets. Int J Cancer 129: 1624-1634.
5. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO (2012) Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol 107: 505-510.
6. Lai KW, Koh KX, Loh M, Tada K, Subramaniam MM, et al. (2010)Micro-MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 46: 1456-1463.
7. Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, et al. (2012) Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res 351: 85-98.
8. Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, et al. (2012) Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 48: 686-691.
9. Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, et al. (2012) Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol. (In press)
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2011) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
11. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
12. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
13. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572. (Pubitemid 37328923)
14. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
15. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, et al. (2012) MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. (In press)
16. Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, et al. (2006) A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131: 830-840. (Pubitemid 44307069)
17. Isaji T, Sato Y, Fukuda T, Gu J (2009) N-glycosylation of the I-like domain of beta1 integrin is essential for beta1 integrin expression and biological function: identification of the minimal N-glycosylation requirement for alpha5beta1. J Biol Chem 284: 12207-12216.
18. Brockbank EC, Bridges J, Marshall CJ, Sahai E (2005) Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo. Br J Cancer 92: 102-112. (Pubitemid 40188442)
19. Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, et al. (2006) Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem 281: 38343-38350. (Pubitemid 46041957)
20. Zhao Y, Nakagawa T, Itoh S, Inamori K, Isaji T, et al. (2006) N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration. J Biol Chem 281: 32122-32130. (Pubitemid 46036766)
21. Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, et al. (2002) The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol 67: 143-153. (Pubitemid 36775506)
22. Miranti CK, Brugge JS (2002) Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-90. (Pubitemid 34308848)
23. Wennerberg K, Armulik A, Sakai T, Karlsson M, Fassler R, et al. (2000) The cytoplasmic tyrosines of integrin subunit beta1 are involved in focal adhesion kinase activation. Mol Cell Biol 20: 5758-5765. (Pubitemid 30482908)
24. Aguirre Ghiso JA, Kovalski K, Ossowski L (1999) Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89-104.
25. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, et al. (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70: 5706-5716.
26. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, et al. (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68: 6241-6250.
27. Shibue T, Weinberg RA (2009) Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci U S A 106: 10290-10295.
28. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, et al. (2010) TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467: 986-990.
29. Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, et al. (2012) Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. (In press)
30. Yang C, Cai J, Wang Q, Tang H, Cao J, et al. (2011) Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol Oncol 124: 325-334.
31. Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, et al. (2010) miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 7: 694-707.
32. Felding-Habermann B (2003) Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20: 203-213.
33. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100. (Pubitemid 37328796)
34. Kemperman H, Driessens M, La Riviere G, Meijne AM, Roos E (1994) The role of integrins and integrin activation in liver metastasis. Invasion Metastasis 14: 98-108.
35. Ramsay AG, Marshall JF, Hart IR (2007) Integrin trafficking and its role in cancer metastasis. Cancer Metastasis Rev 26: 567-578. (Pubitemid 350115108)
36. White DE, Muller WJ (2007) Multifaceted roles of integrins in breast cancer metastasis. J Mammary Gland Biol Neoplasia 12: 135-142. (Pubitemid 47215431)
37. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, et al. (2003) Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201: 229-237. (Pubitemid 37258934)
38. Cannistra SA, Ottensmeier C, Niloff J, Orta B, DiCarlo J (1995) Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol 58: 216-225.
39. Casey RC, Skubitz AP (2000) CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metastasis 18: 67-75. (Pubitemid 32096052)
40. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, et al. (2001) Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7: 1987-1991. (Pubitemid 32994836)
41. Marotta A, Tan C, Gray V, Malik S, Gallinger S, et al. (2001) Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene 20: 6250-6257. (Pubitemid 32964439)
42. Oktay MH, Oktay K, Hamele-Bena D, Buyuk A, Koss LG (2003) Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol 34: 240-245. (Pubitemid 36356676)
43. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, et al. (2002) Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94: 1494-1503. (Pubitemid 35243746)
44. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, et al. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245. (Pubitemid 27167310)
45. Li S, Fu H, Wang Y, Tie Y, Xing R, et al. (2009) MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 49: 1194-1202.
46. Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y, et al. (2013) MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3. PLoS One 8: e73803.
47. Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, et al. (2011) MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18: 2035-2041.
48. Wu X, Weng L, Li X, Guo C, Pal SK, et al. (2012) Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 7: e35661.